Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Infliximab (Atc Code According To Who: L04Ab02)

AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen Germany has Released a tender for Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Infliximab (Atc Code According To Who: L04Ab02) in Pharmaceuticals. The tender was released on Mar 27, 2024.

Country - Germany

Summary - Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Infliximab (Atc Code According To Who: L04Ab02)

Deadline - May 31, 2025

GT reference number - 80162354

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 80162354

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description Conclusion Not Excluding Drug Discount Agreement. According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Infliximab (Atc Code According To Who: L04Ab02)local title: Abschluss nicht exkl. Arzneimi ttel-Rabattvereinb. nach ยง 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Infliximab (ATC-Code nach WHO: L04AB02)type_of_procedure: Otherbidding_response_method: Not Available

Gt Ref Id - 80162354

Deadline - May 31, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database